Please enter the email address you used to register, then we will send you a link to choose a new password
DUO: 151% | Fangdd Network shares are trading higher after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector
MESO: 52% | United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)
APRE: 91% | Aprea Therapeutics shares are trading higher after the company announced FDA Clearance of its IND for APR-1051. The company also announced private placement financing of up to $34 million.
Posted In: APRE DUO MESO